Teva’s new version of Copaxone performs well in key clinical trial

18.06.2012                      28.Siwan. 5772

Pharmazie:

Teva's new version of Copaxone performs well in key clinical trial

But investors are still worried about competition and generic rivals.

Teva Pharmaceutical Industries' new version of its flagship multiple sclerosis drug has proved successful in late clinical trials, giving the company hope it will be able to extend patents and fight competition….